Economic Animal Vaccine Market in China Will Grow with the Development of Large-scale Farming

A few months ago, African swine fever was confirmed in South Korea, marking that this devastating epidemic is still raging in Asia. In the past few months, the aquaculture industry has suffered severe economic losses and consumers’ concerns about food safety have intensified. This African swine fever epidemic will be a powerful boost to the development of the animal health industry, and the animal vaccine industry's secondary sub-industry animal vaccine will also be greatly developed.

Veterinary Biological Industry Increases with Animal Health Industry



In recent years, with the development of the animal husbandry economy, the global animal health market has continued to grow. In 2017, the global market size reached 32 billion US dollars, an increase of 5%. In its several sub-industries, veterinary biological products account for less than 30% of the annual average market due to the low frequency of use.

As for animal vaccine, it is the most important component of veterinary biological products industry, and it also has prominent position in all the secondary sub-industries of animal health industry. With the globally improvement of large-scale farming, animal vaccines will gain a larger market share in the animal health industry as effective epidemic prevention products.


Get FREE Sample of Animal Vaccine Report at: 

https://www.globalmarketmonitor.com/reports/475690-animal-vaccine-market-report.html


Economical Animal Vaccines Determine China’s Animal Vaccine Market

Affected by demand, China has a large number of economic animals, and the market size of its related industries cannot be underestimated. So are the scale of its related industries. In 2017, value of animal health industry in China exceeded 7 billion US dollars, accounting for more than 22% of the global animal health market. And the market scale of its sub-sector – veterinary biological products industry reached 2.2 billion US dollars.

In veterinary biological products industry, animal vaccines are the most important products. In 2017, the market value of animal vaccines in China reached 1.77 billion US dollars, accounting for more than 80% of China's veterinary biological products market. And it even accounted for more than 25% of the whole animal health industry in China.

Veterinary biological products industry accounted for 6.9% of global animal health market in 2017



Animal vaccine took more than a quarter of China animal health market



Animal vaccine can be divided into economical animal vaccine and companion animal vaccine according to the type of the animals. Since companion animals usually enjoy more detailed and comprehensive care than economic animals, even if the number of companion animals is inferior, the market share of the two in the animal health industry is not much different. However, the number of vaccines vaccinated by each animal is limited, so the vaccine for economic animals is absolutely dominant in the animal vaccine market.

Economic animal vaccine determines the Chinese animal vaccine market

As animals can be classified into smaller groups, animal vaccines can also be divided into pig vaccines, poultry vaccines, ruminant vaccines, rabbit vaccines, and vaccine for pets and other animals. In China’s animal vaccine market, poultry vaccines and pig vaccines account for the highest proportion, each accounting for about 35%. The proportion of vaccines for ruminants (sheep, cattle, etc.) is third, accounting for about 27% of the whole. This is also in line with China's food consumption market demand. Vaccines for companion animals and others account for only about 2% of the entire animal vaccine market in China. Pigs, poultry, and ruminants are generally not raised as pets in China, so economic animal vaccines are the main market for animal vaccines in China.


Get Your Custom Report:

https://www.globalmarketmonitor.com/request.php?type=3&rid=475690


Large-scale Farming Will Push Up the Market Value of the Economic Animal Vaccine Industry

The Chinese government is making the development of large-scale farming as a major way of promoting the modernization of aquaculture. China's large-scale production is first used in the pig industry and is expected to be used in the breeding of poultry, ruminants and other economic animals in the future.

The main players of large-scale farming are usually enterprises. At present, the two most common modes are “company + farmers” and the company’s “self-breeding and self-raising factory farming”. In China, representative enterprise of the former is WENS, and of the latter is Muyuan.

By 2020, the degree of large-scale production of pigs in China (the annual output of pigs > 500 heads) will exceed 60%. Compared to retail farming, the vaccination immunization program applied by large-scale farming is more advanced, and the vaccine expenditure per pig has increased, which will push up the market size of China's economic animal vaccine to some extent. The market value of other economic animals will also increase the market value of vaccines. Due to the increasing market demand for food safety and the government's encouragement for large-scale commercial farming, China's economic animal vaccine market will grow steadily in the next few years.

Trends in the scale of China's pig farming (by volume)


Purchase a Copy of Animal Vaccine Report at: 

https://www.globalmarketmonitor.com/request.php?type=3&rid=475690


Status Quo and Forecast of Animal Vaccine Market in China

The research and production of animal vaccine industry in China originated in 1918 and has been under development for hundreds of years.  Since the animal vaccine industry is a highly regulated industry in China, the industry has developed slightly slower than abroad. It was not until 2017 that China entered the market era of animal vaccine. Since then, China's animal vaccine industry has made rapid progress and is now in the stage of independent research and development.

At present, China's animal vaccine industry is highly concentrated. With large and medium-sized enterprises as the backbone, and the industry's head enterprises have basically completed the industrial layout through technological reform, independent research and development, mergers and acquisitions. CAHIC, Jinyu and YEBIO are now the first group. Large and medium-sized enterprises have higher gross profit margins and asset profit margins, which have squeezed the living space of SMEs, and the merger trend is expected to intensify.

The high concentration makes China's medium and large-sized enterprises have higher scientific research capacity and made breakthroughs in various vaccines. After the outbreak of African swine fever epidemic, the Chinese Academy of Agricultural Sciences set up the African swine fever prevention and control science team immediately, and the Harbin Veterinary Research Institute took the lead to jointly tackle the problem with other departments and enterprises. The research is progressing smoothly. In the future, the research cooperation between Chinese animal vaccine-related enterprises and state agencies will be closer.

Although the epidemic has led to a sharp decline in aquaculture retailers and the scale of China's aquaculture will accelerate, but the animal vaccine industry may experience weak growth in the future. When the epidemic prevention system is highly developed, major epidemics may be eliminated, and the demand for animal vaccines will decline. In the United States, epidemic prevention is mainly based on culling, supplemented by prevention. In this way, most epidemics were completely eliminated. Even if the roads are different, all government's epidemic prevention goal is to eliminate the disease. Before that, China’s animal health companies need to open up overseas markets to survive.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.